Efficacy of Immune Checkpoint Inhibitors Differs in Various Status of Carcinoma: A Study Based on 29 Cohorts with 3255 Participants

0
32
Researchers found that the presence of viral infection was evidently associated with improved outcomes in cancer patients undergoing immune checkpoint inhibitors, particularly in cases of HBV/HCV and HPV infections.
[Cancer Immunology Immunotherapy]
Full Article